[go: up one dir, main page]

FI913554L - Förfarande för framställning av en stabiliserad farmaceutisk komposition - Google Patents

Förfarande för framställning av en stabiliserad farmaceutisk komposition Download PDF

Info

Publication number
FI913554L
FI913554L FI913554A FI913554A FI913554L FI 913554 L FI913554 L FI 913554L FI 913554 A FI913554 A FI 913554A FI 913554 A FI913554 A FI 913554A FI 913554 L FI913554 L FI 913554L
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical composition
stabilized pharmaceutical
stabilized
composition
Prior art date
Application number
FI913554A
Other languages
English (en)
Finnish (fi)
Other versions
FI913554A0 (sv
FI98127B (sv
FI98127C (sv
Inventor
Bruce Allan Ross
Richard Victor Vivilecchia
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI913554A0 publication Critical patent/FI913554A0/sv
Publication of FI913554L publication Critical patent/FI913554L/sv
Publication of FI98127B publication Critical patent/FI98127B/sv
Application granted granted Critical
Publication of FI98127C publication Critical patent/FI98127C/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI913554A 1990-07-25 1991-07-24 Förfarande för framställning av en stabiliserad farmaceutisk komposition FI98127C (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (4)

Publication Number Publication Date
FI913554A0 FI913554A0 (sv) 1991-07-24
FI913554L true FI913554L (sv) 1992-01-26
FI98127B FI98127B (sv) 1997-01-15
FI98127C FI98127C (sv) 1997-04-25

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913554A FI98127C (sv) 1990-07-25 1991-07-24 Förfarande för framställning av en stabiliserad farmaceutisk komposition

Country Status (30)

Country Link
EP (1) EP0468929B1 (sv)
JP (1) JP2502849B2 (sv)
KR (1) KR100227156B1 (sv)
AT (1) AT400519B (sv)
AU (1) AU639354B2 (sv)
CA (1) CA2047802C (sv)
CH (1) CH683150A5 (sv)
CZ (1) CZ280184B6 (sv)
DE (1) DE4124409B4 (sv)
DK (1) DK0468929T3 (sv)
ES (1) ES2061218T3 (sv)
FI (1) FI98127C (sv)
GB (1) GB2246296B (sv)
HU (1) HU222489B1 (sv)
IE (1) IE66184B1 (sv)
IL (1) IL98934A (sv)
IT (1) IT1290797B1 (sv)
LU (1) LU87980A1 (sv)
MX (1) MX9100357A (sv)
MY (1) MY107183A (sv)
NO (1) NO912872D0 (sv)
NZ (1) NZ239078A (sv)
PL (1) PL167712B1 (sv)
PT (1) PT98417B (sv)
RU (1) RU2075310C1 (sv)
SA (1) SA92130106B1 (sv)
SK (1) SK278563B6 (sv)
TW (1) TW212757B (sv)
UA (1) UA26064A1 (sv)
ZA (1) ZA915861B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2942495A (en) * 1994-07-13 1996-02-16 Lek Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
TR200003600T2 (tr) * 1998-06-05 2001-04-20 Warner-Lambert Company ACE inhibitörleri içeren bileşimlerin magnezyum oksit kullanılarak sabitlenmesi
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
EP1513555B1 (en) * 2002-01-15 2007-03-28 Actavis Group hf. Formulations of quinapril and related ace inhibitors
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
KR20200013714A (ko) 2017-05-31 2020-02-07 베링거 인겔하임 인터내셔날 게엠베하 (e)-4-(2-(아미노메틸)-3-플루오로알릴옥시)-n-3급-부틸벤즈아미드를 포함하는 약제학적 조성물 및 약제학적 투여 형태, 이들의 제조 방법, 이의 치료 방법 및 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
CA2047802A1 (en) 1992-01-26
IL98934A (en) 1996-07-23
HU222489B1 (hu) 2003-07-28
IL98934A0 (en) 1992-07-15
KR920002146A (ko) 1992-02-28
HU9102385D0 (en) 1991-12-30
ATA147691A (de) 1995-06-15
SA92130106B1 (ar) 2005-10-16
DK0468929T3 (da) 1994-12-27
EP0468929A2 (en) 1992-01-29
FI913554A0 (sv) 1991-07-24
PL291219A1 (en) 1992-08-24
TW212757B (sv) 1993-09-11
PL167712B1 (en) 1995-10-31
AT400519B (de) 1996-01-25
EP0468929A3 (en) 1992-02-19
FI98127B (sv) 1997-01-15
CS230991A3 (en) 1992-04-15
PT98417B (pt) 1999-01-29
KR100227156B1 (ko) 1999-10-15
EP0468929B1 (en) 1994-09-28
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
LU87980A1 (fr) 1993-02-15
IE66184B1 (en) 1995-12-13
UA26064A1 (uk) 1999-04-30
CZ280184B6 (cs) 1995-11-15
SK278563B6 (en) 1997-10-08
IE912608A1 (en) 1992-01-29
RU2075310C1 (ru) 1997-03-20
HUT59819A (en) 1992-07-28
CH683150A5 (de) 1994-01-31
GB9115893D0 (en) 1991-09-04
ITRM910554A0 (it) 1991-07-23
DE4124409A1 (de) 1992-01-30
IT1290797B1 (it) 1998-12-11
DE4124409B4 (de) 2004-11-18
JPH04253923A (ja) 1992-09-09
AU8128691A (en) 1992-01-30
CA2047802C (en) 2003-05-06
NO912872D0 (no) 1991-07-23
ES2061218T3 (es) 1994-12-01
FI98127C (sv) 1997-04-25
JP2502849B2 (ja) 1996-05-29
PT98417A (pt) 1992-06-30
MY107183A (en) 1995-09-30
NZ239078A (en) 1993-10-26
AU639354B2 (en) 1993-07-22
ZA915861B (en) 1993-03-31
ITRM910554A1 (it) 1993-01-23
MX9100357A (es) 1992-02-28

Similar Documents

Publication Publication Date Title
FI914398A7 (sv) Förfarande för framställning av en farmaceutisk sammansättning
FI906249A7 (sv) Förfarande för framställning av en farmaceutisk komposition
FI20000084L (sv) Förfarande för framställning av en antifungal farmaceutisk komposition
FI894342L (sv) Förfarande för framställning av en cyklosporin innehållande farmaceutisk sammansättning
FI892640L (sv) Förfarande för framställning av en piperidinoalkanol-ibuprofenkomposition innehållande farmaceutisk komposition
FI893520L (sv) Förfarande för framställning av en intravenös farmaceutisk sammansättning
FI885884L (sv) Förfarande för framställning av en långsamt frigörande farmaceutisk komposition
FI921021A7 (sv) Förfarande för framställning av trans-Pt(IV)-föreningar
FI921174L (sv) Förfarande för framställning av metyletrar
FI912109A7 (sv) Förfarande för framställning av en polymerkomposition
FI891570L (sv) Förfarande för framställning av farmaceutiska sammansättningar av piroxikam
FI925988A7 (sv) Förfarande för framställning av B-laktamer
FI895766A7 (sv) Förfarande för framställning av nya lysosfingolipider
FI914988A7 (sv) Förfarande för framställning av en näringsblandning
FI932552A7 (sv) Förfarande för framställning av en fast enhet doseringsform för regler ad utlösningen
FI20001776L (sv) Förfarande för framställning av farmaceutisk komposition
FI913554L (sv) Förfarande för framställning av en stabiliserad farmaceutisk komposition
FI912868A7 (sv) Förfarande för framställning av farmaceutiska föreningar
FI940280L (sv) Förfarande för framställning av demetylepydofyllotoxin
FI923498A7 (sv) Förfarande för framställning av 3-deoximannosaminderivat
FI911420L (sv) Förfarande för framställning av terapeutiskt användbara föreningar
PT87672A (pt) Process for preparing a pharmaceutical composition
FI923799A7 (sv) Förfarande för framställning av metylacetat
FI910366L (sv) Förfarande för framställning av deoximulundokandin
FI923360A7 (sv) Förfarande för framställning av dimetylacetoacetamid

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired